Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Mitesco, Inc. (MITI : OTC)

• Company Description    Mitesco Inc. is holding company for MyCare, LLC. It is building out a network of clinics using telehealth technology with the nurse practitioner operating as its primary healthcare provider. Mitesco Inc., formerly known as True Nature Holding Inc., is based in Denver, CO. Number of Employees: 3

• Price / Volume Information    Yesterday's Closing Price: $0.20 Daily Weekly Monthly 20 Day Moving Average: 46,055 shares Shares Outstanding: 12.32 (millions) Market Capitalization: $2.42 (millions) Beta: 2.06 52 Week High: $0.78 52 Week Low: $0.10 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 40.29% 37.82% 12 Week -40.49% -45.94% Year To Date -57.30% -52.45%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 505 BEACHLAND BLVD. SUITE 1377 - VERO BEACH,FL 32963 USA ph: 844-383-8689 fax: 866-331-2441 jimmycaplan@me.com https://mitescoinc.com

• General Corporate Information    Officers Mack Leath - Chief Executive Officer; Chief Financial Officer a John Mitchell - Secretary and Director Jordan Balencic - Director Thomas Brodmerkel - Chief Financial Officer Juan Carlos Iturregui Esq - Director Peer Information - (-) - (-) - (-) - (-) - (-) - (-) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 60672T206 SIC: 7370 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/25 Next Expected EPS Date: 11/24/25 Share - Related Items Shares Outstanding: 12.32 Most Recent Split Date: 12.00 (0.02:1) Beta: 2.06 Market Capitalization: $2.42 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio: Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/24/25

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 32.60 EPS Growth vs. Year Ago Period: 93.33% vs. Previous Quarter: 87.50% Sales Growth vs. Year Ago Period: 216.67% vs. Previous Quarter: 11.76% ROE 06/30/25 - - 03/31/25 - - 12/31/24 - - ROA 06/30/25 - -744.83 03/31/25 - -1,202.21 12/31/24 - -5,512.23 Current Ratio 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Quick Ratio 06/30/25 - 0.00 03/31/25 - 0.00 12/31/24 - 0.00 Operating Margin 06/30/25 - -1,534.40 03/31/25 - -2,391.38 12/31/24 - - Net Margin 06/30/25 - 1,639.45 03/31/25 - 1,456.66 12/31/24 - - Pre-Tax Margin 06/30/25 - 1,638.94 03/31/25 - 1,456.66 12/31/24 - -5,748.28 Book Value 06/30/25 - -1.88 03/31/25 - -1.99 12/31/24 - -2.70 Inventory Turnover 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Equity 06/30/25 - - 03/31/25 - - 12/31/24 - - Debt-to-Capital 06/30/25 - - 03/31/25 - - 12/31/24 - -

Powered by Zacks Investment Research ©